HTB
-
Featured
HTB: no. 2 – plus HIV and COVID-19 (24 February 2021)
24 February 2021. Related: Editorial.
-
Featured
HTB: no. 1 – plus HIV and COVID-19 (22 January 2021)
22 January 2021. Related: Editorial.
-
Featured
HTB: no. 13/14 – HIV and COVID-19: issue 10 (9 December 2020)
9 December 2020. Related: Editorial.
-
Featured
HTB: no. 12 – HIV and COVID-19: issue 9 (11 November 2020)
11 November 2020. Related: Editorial.
-
Featured
In Memory: Timothy Ray Brown, the Berlin patient, the first person to be cured of HIV
14 October 2020. Related: In Memory.
-
Ivermectin has no impact in treating mild COVID-19 in 400 adults in Columbia
6 March 2021. Related: Early access, COVID-19: investigational drugs, COVID-19.
-
No benefit from BRII and GSK monoclonal antibodies against COVID-19 in ACTIV-3 study
5 March 2021. Related: Early access, COVID-19: investigational drugs, COVID-19.
-
Chronic kidney disease (CKD) in HIV positive people linked to time with low CD4 count: partly reversible after effective ART
1 March 2021. Related: Early access, Side effects, OIs, coinfections and complications.
-
i-Base appeal: please support i-Base with £5 or £10 a month
24 February 2021. Related: Editorial.
-
In memory: Elias Phiri, community HIV and TB advocate
24 February 2021. Related: In Memory.
-
In memory: Dr Joseph Sonnabend, pioneer HIV activist and researcher
24 February 2021. Related: In Memory.
-
Timothy Ray Brown: a virtual memorial
24 February 2021. Related: In Memory.
-
R4P virtual conference (2021)
24 February 2021. Related: Conference reports, HIV prevention and transmission, Conference index, R4P 2021 Virtual.
-
VRC01 antibody only prevents minority of HIV infections: AMP study results
24 February 2021. Related: Conference reports, HIV prevention and transmission, R4P 2021 Virtual.
-
Long-acting bNAb is safe and well tolerated and achieves target concentrations in newborns (VRC07-523LS)
24 February 2021. Related: Conference reports, Paediatric care, HIV prevention and transmission, R4P 2021 Virtual.
-
Promising data for multipurpose technologies to prevent HIV and pregnancy
24 February 2021. Related: Conference reports, Pregnancy, HIV prevention and transmission, R4P 2021 Virtual.
-
12th International Workshop on HIV paediatrics
24 February 2021. Related: Conference reports, Conference index, 12th Paediatric HIV 2020.
-
New LPV/r-based fixed dose HIV combination for young children: first results with Quadrimune 4-in-1
24 February 2021. Related: Conference reports, Paediatric care.
-
UK study for people with triple-class drug resistance
24 February 2021. Related: Resistance, Research studies.
-
Community murals in Soweto on dolutegravir-based ART: an i-Base collaboration
24 February 2021. Related: Treatment advocacy.
-
HIV positive people in the UK now elligible for COVID vaccinations – and to become available at HIV clinics
24 February 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19: treatment access, COVID-19.
-
Main COVID-19 variants and their likely impact on vaccines
24 February 2021. Related: COVID-19: vaccine research, COVID-19: transmission & prevention, COVID-19.
-
Novavax: >90% efficacy in UK but 60% in South Africa, hints of lower effect in HIV positive participants
24 February 2021. Related: COVID-19: vaccine research, COVID-19.
-
Russian Sputnik vaccine reports 91% efficacy at 21 days after the first dose
24 February 2021. Related: COVID-19: vaccine research, COVID-19.
-
Janssen vaccine reports efficacy after single injection: FDA decision imminent
24 February 2021. Related: COVID-19: vaccine research, COVID-19.
-
Oxford/AZ vaccine might still prevent severe COVID-19 from B.1.351 variant: supports continued used in South Africa
24 February 2021. Related: COVID-19: vaccine research, COVID-19.
-
Unprecedented rapid speed of COVID vaccine development
24 February 2021. Related: COVID-19: vaccine research, COVID-19.
-
WHO online vaccine tracker
24 February 2021. Related: COVID-19: vaccine research, COVID-19.
-
COVID-19 vaccine pricing: a BBC guide
24 February 2021. Related: COVID-19: vaccine research, COVID-19: treatment access, COVID-19.
-
High rates of undocumented COVID-19 mortality in Zambia without testing challenges the idea that Africa has been spared
24 February 2021. Related: COVID-19: treatment access, COVID-19: pathogenesis.
-
Tocilizimab effectively reduces COVID-19 related deaths and hospitalisation time: additive benefit with dexamethasone
24 February 2021. Related: COVID-19: investigational drugs, COVID-19.
-
Bamlanivimab (LY-CoV555) prophylaxis prevents COVID-19 in care homes: results of BLAZE-2 study
24 February 2021. Related: COVID-19: investigational drugs, COVID-19.
-
US FDA specifies high antibody titre for convalescent plasma and to only use in early COVID-19
24 February 2021. Related: COVID-19: investigational drugs, COVID-19.
-
No benefit from convalescent plasma in UK RECOVERY study: limited results restrict implications for COVID-19
24 February 2021. Related: COVID-19: investigational drugs, COVID-19.
-
UK variant B.1.1.7 linked to higher risk of death and hospitalisation from COVID-19
24 February 2021. Related: COVID-19: pathogenesis, COVID-19.
-
Future meetings and webinars 2021
24 February 2021. Related: Future meetings.
-
HTB no 2 – plus HIV and COVID-19 (24 February 2021)
24 February 2021. Related: PDFs.
-
BHIVA 2020 virtual conference now online
22 January 2021. Related: Conference reports, Conference index, BHIVA 2020 virtual.
-
Single undetectable viral load is sufficient for U=U in the context of good adherence
22 January 2021. Related: Conference reports, HIV prevention and transmission, BHIVA 2020 virtual.
-
Selected plenary talks and workshops from BHIVA 2020
22 January 2021. Related: Conference reports, Other news, On the web.
-
US FDA approves long-acting injectable HIV treatment: monthly dosing
22 January 2021. Related: Antiretrovirals.
-
Long-acting injectable HIV treatment approved in the EU: includes two-monthly dosing
22 January 2021. Related: Antiretrovirals.
-
Fostemsavir approved in the EU (Rukobia): NICE deferred in the UK
22 January 2021. Related: Antiretrovirals.
-
PHE report on HIV and STIs during COVID-19
22 January 2021. Related: HIV prevention and transmission.
-
Baseline NNRTI resistance linked to poorer response to first-line dolutegravir in the ADVANCE study
22 January 2021. Related: Treatment strategies, Resistance.
-
Significant increases in LGV in gay men from 2017 to 2019: latest PHE report
22 January 2021. Related: OIs, coinfections and complications, Other news.
-
HIV criminalisation during 2020: cases continue but also legal advances
22 January 2021. Related: Other news.
-
NICE issue UK guidelines on long COVID
22 January 2021. Related: COVID-19: guidelines, COVID-19.
-
BHIVA and EACS update HIV as a higher risk for COVID-19: supports priority vaccine (January 2021)
22 January 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
-
Recent studies on HIV and COVID-19 coinfection
22 January 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
-
Very low-level HIV viraemia might continue after COVID-19
22 January 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: pathogenesis, COVID-19.
-
Pfizer COVID-19 vaccine might still overcome UK and SA variants
22 January 2021. Related: COVID-19: vaccine research, COVID-19.
-
Novavax phase 3 vaccine study launched in the UK, South Africa, US, Mexico and Puerto Rico
22 January 2021. Related: COVID-19: vaccine research, COVID-19.